New Zealand currently regulates medical devices under the Medicines Act 1981. Although the Therapeutic Products Act was passed in 2023,...
Read More
Process Validation in Pharmaceuticals: 2026 Regulatory Expectations, Modern Methods, & Industry Best Practices
Read More
Although REMS are relatively rare—fewer than 100 approved REMS programs are active today—the burden of compliance for affected companies is...
Read More
In this case, it means replacing a reference product with a biosimilar that will provide the same clinical outcomes
Read More
Drug safety involves ensuring that the right medication is given to the right patient at the right time to enhance...
Read More
The biopharmaceutical landscape is at a pivotal moment as biosimilars—therapeutic products that closely resemble and are clinically equivalent to existing...
Read More
Pharmacovigilance (PV) is defined by the World Health Organization (WHO) as “the science and activities relating to the detection, assessment,...
Read More